The US Justice Department has asked the Supreme Court to intervene in the Texas medication abortion drug dispute which concerns the Food and Drug Administration's (FDA) authority to regulate a drug used in the majority of abortions in states which allow the procedure. The case seeks to overturn a broad ruling by US District Court Judge Matthew Kacsmaryk which blocks the FDA's approval of the drug, as well as changes made during subsequent years to make it more accessible. The case is the most significant abortion-related dispute to reach the Supreme Court since it overturned Roe v. Wade last year. The FDA-approved medication, Mifepristone, would no longer have access to market, restricting many women’s access to medication-based abortions. The clock is ticking for the Supreme Court to decide on whether to intervene as the lower court's amended ruling is due to come in effect at midnight (CT). The court has been asked to freeze the lower court opinion or agree to hear arguments before the summer recess.